“In recognition of our innovative green biotechnology process to sustainably produce phytochemical ingredients, we are one of three Canadian applicants of the Open Innovation Call initiative selected for follow-up conversations. This initiative is a partnership between Natural Products Canada and Schwabe/Nature’s Way, a global leader in phyto innovation and natural health. It set out to find innovators developing science-based solutions in Central nervous system health, Gastroenterology and digestion, and Cough and Cold,” says Patrick Charest B. Sc., P. Eng., CEO.

We are excited to drive our conversations on brain health with Schwabe/Nature’s Way to the next level.

Canada’s natural and bio-based innovation ecosystem is attracting global interest.

” We were impressed by both the volume and quality of applications,” says Dr. Dirk Bredenbröker, MD, Executive Vice President of research and development at Schwabe Group. ” There was a broad selection and variety of approaches to our priority areas that we found intriguing.”

” The results reflect the depth, diversity, and scientific strength of Canada’s innovators in natural health and their potential to shape the future of plant-based health and wellness. This collaboration demonstrates the real commercial relevance of the companies in our pipeline — and the value of open innovation in bridging global demand with homegrown ingenuity,” underlines Shelley King, M. Sc., MBA, CEO, Natural Products Canada.

” In line with our work on nootropics, we look forward to completing win-win discussions with Schwabe/Nature’s Way in the immediate future,” concludes Patrick Charest.

Share : Back to blog